Raffles Medical Group Ltd (RAFLF) Comparison with companies in other sectors?

Raffles Medical Group Ltd has a share price of 1.86B. You can analyze Raffles Medical Group Ltd (RAFLF) competitors across different market sectors through stock heatmaps.

What are RAFLF's NET and operating margins?

Raffles Medical Group Ltd (RAFLF) operating margin is around 0.11, and net profit margin is approximately 0.09 as of the latest reports.

In what way does RAFLF's earnings per share (EPS) trend reflect its financial momentum?

Raffles Medical Group Ltd (RAFLF) EPS is 0.03 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Raffles Medical Group Ltd is 26.91, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Raffles Medical Group Ltd?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Raffles Medical Group Ltd like P/E which is 42.71, P/B which is 1.86, and PEG which is -1.70. Compare them with sector averages to evaluate if the stock is priced fairly.

Raffles Medical Group Ltd

RAFLF•PNK

Healthcare

Medical - Care Facilities

$0.81

$0.06(7.64%)

Fundamental Analysis of Raffles Medical Group Ltd (RAFLF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.03

P/E Ratio

26.91

ROE

0.04%

Net Margin

0.09%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.50B

Shares OutstandingTotal number of shares issued

$1.86B

Book Value/ShareNet worth per share

$0.56

Revenue/ShareAnnual revenue per share

$0.28

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.03

Net MarginNet income as percentage of revenue

8.57%

Operating MarginOperating income as percentage of revenue

10.68%

ROEReturn on shareholders' equity

4.46%

ROAReturn on total assets

2.99%

ROCEReturn on capital employed

4.96%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.03

Cash/ShareCash and equivalents per share

$0.18

FCF YieldFree cash flow as percentage of market cap

2.53%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.02

Dividend YieldAnnual dividend as percentage of stock price

2.39%

Financial Ratios Analysis data is not available for RAFLFFinancial Ratios Analysis details for RAFLF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for RAFLFSector Benchmarking details for RAFLF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Raffles Medical Group Ltd Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Raffles Medical Group Ltd. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Raffles Medical Group Ltd's unique business strengths and challenges.

Key Financial Metrics for Raffles Medical Group Ltd

For Raffles Medical Group Ltd, essential financial indicators include EPS 0.03, PE 26.91, and ROE 0.04. These key ratios reveal insights into Raffles Medical Group Ltd's profitability, valuation, and operational health. Understanding these metrics enables you to compare Raffles Medical Group Ltd with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Raffles Medical Group Ltd

Metrics like Net Margin 8.57% and ROA 2.99% shed light on how well Raffles Medical Group Ltd is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Raffles Medical Group Ltd can sustain its operations and continue growing in the future.

Valuation and Market Position of Raffles Medical Group Ltd

Using ratios such as P/B Ratio 1.86 and PEG Ratio -1.70, investors can assess whether Raffles Medical Group Ltd is appropriately valued based on its financials and growth potential. These figures, combined with Raffles Medical Group Ltd's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Raffles Medical Group Ltd

Financial health indicators, such as Debt/Equity Ratio 0.08 and Cash Flow $0.03, provide a snapshot of Raffles Medical Group Ltd's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Raffles Medical Group Ltd, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Raffles Medical Group Ltd

Investing in Raffles Medical Group Ltd based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Raffles Medical Group Ltd focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;